Commented glossary for rheumatic spinal diseases.

od Braun, J, Sieper, J
Wydane 1996

Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.

od Kingsley, G, Sieper, J
Wydane 1996

Anti-TNFα: a new dimension in the pharmacotherapy of the spondyloarthropathies !?

od BRAUN, J, SIEPER, J
Wydane 2000

New treatment options in ankylosing spondylitis: a role for anti-TNFα therapy

od Sieper, J, Braun, J
Wydane 2001

Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care

od Sieper, J, Rudwaleit, M
Wydane 2005

Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New T...

od Braun, J, Sieper, J
Wydane 2002

How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?

od Sieper, J, Rudwaleit, M
Wydane 2005

Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?

od Braun, J, Khan, M, Sieper, J
Wydane 2000

Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside

od Rudwaleit, M, Feldtkeller, E, Sieper, J
Wydane 2006

Divergent T-cell cytokine patterns in inflammatory arthritis.

od Simon, A K, Seipelt, E, Sieper, J
Wydane 1994

Low incidence of reactive arthritis in children following a salmonella outbreak

od Rudwaleit, M, Richter, S, Braun, J, Sieper, J
Wydane 2001

T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis.

od Sieper, J, Braun, J, Wu, P, Kingsley, G
Wydane 1993

Definition of discontinuation of anti-tumour necrosis factor therapy in rheumatoid arthritis: a preliminary proposal

od Braun, J, Sieper, J, van der Heijde, D
Wydane 2003

Six months open label trial of leflunomide in active ankylosing spondylitis

od Haibel, H, Rudwaleit, M, Braun, J, Sieper, J
Wydane 2005

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

od Haibel, H, Rudwaleit, M, Listing, J, Sieper, J
Wydane 2005

Ist eine Delegation ärztlicher Leistungen auf rheumatologische Fachassistenten bei der Evaluierung von Patienten mit Verdacht auf ankylosierende Spondylitis möglich? – Ergebnisse d...

od Kiltz, U., Spiller, I., Sieper, J., Braun, J.
Wydane w Z Rheumatol (2020)

Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and tra...

od François, R J, Neure, L, Sieper, J, Braun, J
Wydane 2006

Antigen-dependent B cell differentiation in the synovial tissue of a patient with reactive arthritis.

od Schröder, A. E., Sieper, J., Berek, C.
Wydane 1997

Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis

od Rudwaleit, M, Listing, J, Brandt, J, Braun, J, Sieper, J
Wydane 2004

Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis

od Zou, J, Appel, H, Rudwaleit, M, Thiel, A, Sieper, J
Wydane 2005